4.1 Article

The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2in Spain

Journal

JOURNAL OF MEDICAL ECONOMICS
Volume 16, Issue 7, Pages 926-938

Publisher

Informa Healthcare
DOI: 10.3111/13696998.2013.803110

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available